[Ceftriaxone: whether there is future for it?].
Sidorenko
S V
SV
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D003428:Cross Infection / Q000188:drug therapy; D024881:Drug Resistance, Bacterial; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy; D010031:Otitis / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone